A detailed history of Cetera Investment Advisers transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 27,091 shares of CORT stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,091
Previous 38,292 29.25%
Holding current value
$1.41 Million
Previous $1.24 Million 0.72%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$29.51 - $46.26 $330,541 - $518,158
-11,201 Reduced 29.25%
27,091 $1.25 Million
Q2 2024

Aug 22, 2024

BUY
$22.21 - $34.48 $49,839 - $77,373
2,244 Added 6.23%
38,292 $1.24 Million
Q1 2024

May 24, 2024

BUY
$21.1 - $27.46 $760,612 - $989,878
36,048 New
36,048 $908,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.59B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.